Aberdeen Group plc Grows Stake in Intuitive Surgical, Inc. $ISRG

Aberdeen Group plc lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 388,076 shares of the medical equipment provider’s stock after buying an additional 62,446 shares during the quarter. Aberdeen Group plc owned about 0.11% of Intuitive Surgical worth $173,559,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Tobam increased its stake in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Finally, Guerra Advisors Inc bought a new stake in shares of Intuitive Surgical in the third quarter worth about $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the transaction, the director directly owned 15,720 shares in the company, valued at $8,355,494.40. This represents a 15.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the sale, the senior vice president directly owned 131 shares of the company’s stock, valued at $71,852.19. The trade was a 77.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 56,189 shares of company stock worth $30,785,441 in the last three months. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Piper Sandler reissued an “overweight” rating and set a $620.00 target price (up previously from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Leerink Partners upped their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Robert W. Baird reduced their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Finally, HSBC boosted their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $485.84 on Friday. The company’s 50 day simple moving average is $541.62 and its 200-day simple moving average is $510.34. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The company has a market capitalization of $172.54 billion, a price-to-earnings ratio of 61.58, a price-to-earnings-growth ratio of 3.76 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.